Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#312 of 589

Douglas Tsao

HC Wainwright & Co. · Equity Research Analyst
EstablishedRating since 2021No new ratings since Oct 2025

Analyst rating accuracy & track record

Douglas Tsao is an equity research analyst at HC Wainwright & Co.. Quantellect has scored 127 of their stock calls across 22 companies. Their picks beat their sector 35% of the time over the next 12 months, and their price targets were reached 16% of the time within a year.

Win % vs sector
35%
PT Hit % (12mo)
16%
Avg sector-excess
−5.8%
Scored calls
127
Tickers
22
Tier
Established

Track record

Quantellect has scored 127 of Douglas Tsao's stock calls across 22 companies, dating back to 2021. Their rated stocks beat their own sector 35% of the time over the next 12 months. On a typical call, a Tsao pick returned −5.8% more than its sector over the following year.

Of the scored calls, 127 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ARGXargenx NV ADR
Buy$915.00Oct 2025−23.0%Hit
CABACabaletta Bio Inc
Buy$16.00Oct 2025−50.3%Miss
PTGXProtagonist Therapeutics Inc
Buy$80.00Oct 2025+91.1%Hit
PTGXProtagonist Therapeutics Inc
Buy$80.00Sep 2025+107.3%Hit
IMVTImmunovant Inc
Buy$35.00Sep 2025+103.1%Hit
RZLTRezolute Inc
Buy$14.00Sep 2025−66.2%Miss
EVOEvotec SE ADR
Buy$7.00Aug 2025−72.3%Miss
BHVNBiohaven Ltd.
Buy$30.00Aug 2025−28.0%Miss
EOLSEvolus Inc
Buy$20.00Aug 2025−7.1%Miss
IRONDisc Medicine Inc.
Buy$118.00Jul 2025+22.2%Miss
IRONDisc Medicine Inc.
Buy$118.00Jun 2025+25.5%Miss
CABACabaletta Bio Inc
Buy$25.00Jun 2025+52.6%Miss
XENEXenon Pharmaceuticals Inc
Buy$53.00May 2025+71.9%Hit
CHRSCoherus BioSciences Inc
Buy$7.00Apr 2025+65.4%Miss
RZLTRezolute Inc
Buy$14.00Apr 2025−25.6%Miss
EOLSEvolus Inc
Buy$27.00Apr 2025−64.8%Miss
ARQTArcutis Biotherapeutics Inc
Buy$19.00Apr 2025+50.5%Hit
DAREDare Bioscience Inc
Buy$12.00Apr 2025−38.9%Miss
CABACabaletta Bio Inc
Buy$25.00Apr 2025+111.9%Miss
IMVTImmunovant Inc
Buy$51.00Mar 2025+18.6%Miss
CHRSCoherus BioSciences Inc
Buy$7.00Mar 2025+74.1%Miss
NMRANeumora Therapeutics, Inc.
Buy$18.00Mar 2025+134.0%Miss
EOLSEvolus Inc
Buy$27.00Mar 2025−63.0%Miss
NMRANeumora Therapeutics, Inc.
Buy$18.00Mar 2025+106.5%Miss
APLSApellis Pharmaceuticals Inc
Buy$57.00Mar 2025−27.2%Miss
Prev1
Go to

Douglas Tsao: analyst track record FAQ

Is Douglas Tsao a good stock analyst?

Yes, by track record. Douglas Tsao ranks number 312 of 589 of the analysts Quantellect scores, with an Analyst Score of 33 out of 100. Past results do not guarantee future ones.

What is Douglas Tsao's win rate?

Douglas Tsao's win rate is 35%. Across 127 scored calls, their rated stocks beat their sector 35% of the time over the next 12 months. On a typical call they returned −5.8% more than the sector.

What stocks and sectors does Douglas Tsao cover?

Douglas Tsao covers 22 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Douglas Tsao's price targets accurate?

Douglas Tsao's price targets are reached within 12 months 16% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Douglas Tsao's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Douglas Tsao rank among Wall Street analysts?

Douglas Tsao ranks number 312 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.